Acinetobacter baumannii is a bacteria which can become a virulent killer in health-care settings among severely ill patients. The germ has rapidly developed drug resistance to even last-line carbapenem drugs. Now a group of Hackensack Meridian Center for Discovery and Innovation (CDI) scientists have found a way to understand how the germ is evolving—and how best to strategize a fight against it.